Provantis Preclinical Solution Chosen from Competitive Evaluation to Replace In-House Systems and Manual Processes
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a premier global information solutions provider, announced today that Cephalon, Inc. will be deploying version 8 of the integrated preclinical solution Provantis(TM) in early 2008.
Seeking to speed up and optimize their study protocol and report production processes, Cephalon’s evaluation team sought a proven preclinical solution that was based on familiar windows-based powerhouse applications such as Oracle and SAS.
“Instem integrates the documentation aspects of a toxicology laboratory with the powerful data management of Provantis and Oracle that will provide us with real business benefits we can measure,” comments Sebastien Girault, Director of Drug Safety at Cephalon. “One of the most anticipated areas of improvement is in reporting, where increasing speed and accuracy with a solution that is easy to learn and use will assist us in producing higher quality documents for internal and external use.”
Provantis(TM) is a modern, fully integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies. The solution suite streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
“It’s exciting to be part of Cephalon’s growth plans and we look forward to deploying Provantis so they can more efficiently collect and process their data enabling faster decisions for the organization,” comments Neil Donaldson, Business Development Manager at Instem.
Provantis is offered to single users and global laboratories through traditional on-site deployments as well as Instem’s Software-as-a-Service (SaaS) model, where clients access Provantis on-demand over the Internet.
About Cephalon, Inc.
Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. The company has laboratories in West Chester, Pennsylvania, Salt Lake City, Utah, suburban Minneapolis, Minnesota and Maisons-Alfort, France.
About Instem
Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products.
Established in 1969, Instem has offices in the United States and Europe with its preclinical solutions supported in fifteen countries. Instem’s customer base consists of the leading pharmaceutical, chemical and contract research organizations, including government and privately funded programs across sites worldwide.
Instem serves organizations of all sizes in overcoming the challenges of managing information and provides solutions that help them further their missions while creating a competitive advantage.
For more information on Instem and its solutions, please visit www.instem-lss.com or contact them by email at info@instem-lss.com.
Press Contact: Instem Gary E. Mitchell, VP Global Marketing, Instem US HQ Tel: 610-941-0990 Email: gary.Mitchell@instem-lss.com
Source: Instem
